Effect of cognitive behaviour therapy on anxiety, depression and breathlessness in patients with Chronic Obstructive Pulmonary Disease (COPD): A randomised controlled trial.

Westmead hospital0 个研究点目标入组 60 人开始时间: 2017年5月5日最近更新: 2022年8月9日

适应症

试验速览

暂无简介。

•a) Severe or very severe COPD by Gold criteria (FEV1<60% predicted; FEV1/FVC ratio <70%).
•b) Breathlessness (modified Medical Research Council dyspnea scale scores (mMRC > 2).
•c) Completion of the Westmead Hospital Breathlessness Clinic within 9 months
•d) Elevated anxiety or depression scores (Hospital Anxiety and Depression Scale - Anxiety score > 8 or Hospital Anxiety and Depression Scale - Depression score> 8).

•a) A history of a recent (< 4 weeks) moderate to severe exacerbation of COPD, requiring hospitalisation.
•b) Bed bound.
•c) A diagnosis of dementia or cognitive impairment.
•d) Insufficient proficiency in English for participation in CBT.
•e) A current active diagnosis of cancer, other primary respiratory disease, substance abuse, other uncontrolled medical disorder.
•f) Inability to comply with study procedures in the opinion of the investigators or the participant’s usual medical team
•g) already receiving psychological intervention

发起方

Westmead hospital